188 related articles for article (PubMed ID: 3746530)
1. Insulin-like growth factors I and II in evaluation of growth retardation.
Rosenfeld RG; Wilson DM; Lee PD; Hintz RL
J Pediatr; 1986 Sep; 109(3):428-33. PubMed ID: 3746530
[TBL] [Abstract][Full Text] [Related]
2. Growth hormone treatment in short children: relationship between growth and serum insulin-like growth factor I and II levels.
Albertsson-Wikland K; Hall K
J Clin Endocrinol Metab; 1987 Oct; 65(4):671-8. PubMed ID: 3654912
[TBL] [Abstract][Full Text] [Related]
3. Molecular forms of serum insulin-like growth factor (IGF)-binding proteins in man: relationships with growth hormone and IGFs and physiological significance.
Hardouin S; Gourmelen M; Noguiez P; Seurin D; Roghani M; Le Bouc Y; Povoa G; Merimee TJ; Hossenlopp P; Binoux M
J Clin Endocrinol Metab; 1989 Dec; 69(6):1291-301. PubMed ID: 2555386
[TBL] [Abstract][Full Text] [Related]
4. Clinical utility of insulin-like growth factor assays.
Lee PD; Rosenfeld RG
Pediatrician; 1987; 14(3):154-61. PubMed ID: 3331010
[TBL] [Abstract][Full Text] [Related]
5. Changes in insulin-like growth factors I and II and their binding protein after a single intramuscular injection of growth hormone.
Grant MB; Schmetz I; Russell B; Harwood HJ; Silverstein J; Merimee TJ
J Clin Endocrinol Metab; 1986 Oct; 63(4):981-4. PubMed ID: 3018033
[TBL] [Abstract][Full Text] [Related]
6. Clinical relevance of serum measurements of insulin-like growth factors and somatomedin binding proteins.
Ranke MB; Blum WF; Bierich JR
Acta Paediatr Scand Suppl; 1988; 347():114-26. PubMed ID: 2473597
[TBL] [Abstract][Full Text] [Related]
7. Somatomedin C in pediatric pathophysiology.
Cacciari E; Cicognani A
Pediatrician; 1987; 14(3):146-53. PubMed ID: 3453495
[TBL] [Abstract][Full Text] [Related]
8. Use of insulin-like growth factor-binding protein-2 (IGFBP-2), IGFBP-3, and IGF-I for assessing growth hormone status in short children.
Smith WJ; Nam TJ; Underwood LE; Busby WH; Celnicker A; Clemmons DR
J Clin Endocrinol Metab; 1993 Nov; 77(5):1294-9. PubMed ID: 7521346
[TBL] [Abstract][Full Text] [Related]
9. Levels of growth hormone, insulin-like growth factor-I (IGF-I) and -II, IGF-binding protein-1 and -3, and cortisol in prednisone-treated children with growth retardation after renal transplantation.
Hokken-Koelega AC; Stijnen T; de Muinck Keizer-Schrama SM; Blum WF; Drop SL
J Clin Endocrinol Metab; 1993 Oct; 77(4):932-8. PubMed ID: 7691864
[TBL] [Abstract][Full Text] [Related]
10. Serum insulin-like growth factors I and II concentrations and growth hormone and insulin responses to arginine infusion in children with protein-energy malnutrition before and after nutritional rehabilitation.
Soliman AT; Hassan AE; Aref MK; Hintz RL; Rosenfeld RG; Rogol AD
Pediatr Res; 1986 Nov; 20(11):1122-30. PubMed ID: 3099250
[TBL] [Abstract][Full Text] [Related]
11. The measurement of insulin-like growth factor I: clinical applications and significance.
Teale JD; Marks V
Ann Clin Biochem; 1986 Jul; 23 ( Pt 4)():413-24. PubMed ID: 3094423
[TBL] [Abstract][Full Text] [Related]
12. Increase in specific binding of insulin-like growth factor (IGF) II to type 1 IGF receptors on erythrocytes of hypopituitary children receiving growth hormone therapy.
Costigan CD; Polychronakos C; Guyda HJ; Posner BI
Clin Invest Med; 1988 Feb; 11(1):47-51. PubMed ID: 2966692
[TBL] [Abstract][Full Text] [Related]
13. Growth hormone deficiency impedes the rise in plasma insulin-like growth factor I levels associated with precocious puberty.
Cara JF; Burstein S; Cuttler L; Moll GW; Rosenfield RL
J Pediatr; 1989 Jul; 115(1):64-8. PubMed ID: 2738797
[TBL] [Abstract][Full Text] [Related]
14. Somatomedin binding proteins in GH-deficient children with normal plasma somatomedin levels.
Cohen DA; Blethen SL
J Clin Endocrinol Metab; 1983 Mar; 56(3):461-6. PubMed ID: 6185524
[TBL] [Abstract][Full Text] [Related]
15. Kinetics of the somatomedin C/insulin-like growth factor I: response to exogenous growth hormone (GH) in GH-deficient children.
Blethen SL; Daughaday WH; Weldon VV
J Clin Endocrinol Metab; 1982 May; 54(5):986-90. PubMed ID: 7037825
[TBL] [Abstract][Full Text] [Related]
16. Growth hormone (GH) provocative testing frequently does not reflect endogenous GH secretion.
Bercu BB; Shulman D; Root AW; Spiliotis BE
J Clin Endocrinol Metab; 1986 Sep; 63(3):709-16. PubMed ID: 3525601
[TBL] [Abstract][Full Text] [Related]
17. Twenty-four-hour plasma growth hormone (GH) profiles, urinary GH excretion, and plasma insulin-like growth factor-I and -II levels in prepubertal children with chronic renal insufficiency and severe growth retardation.
Hokken-Koelega AC; Hackeng WH; Stijnen T; Wit JM; de Muinck Keizer-Schrama SM; Drop SL
J Clin Endocrinol Metab; 1990 Sep; 71(3):688-95. PubMed ID: 2394775
[TBL] [Abstract][Full Text] [Related]
18. Influence of nutritional status and oestradiol-17 beta on plasma growth hormone, insulin-like growth factors-I and -II and the response to exogenous growth hormone in young steers.
Breier BH; Gluckman PD; Bass JJ
J Endocrinol; 1988 Aug; 118(2):243-50. PubMed ID: 3171467
[TBL] [Abstract][Full Text] [Related]
19. Short stature associated with high circulating insulin-like growth factor (IGF)-binding protein-1 and low circulating IGF-II: effect of growth hormone therapy.
Barreca A; Bozzola M; Cesarone A; Steenbergh PH; Holthuizen PE; Severi F; Giordano G; Minuto F
J Clin Endocrinol Metab; 1998 Oct; 83(10):3534-41. PubMed ID: 9768660
[TBL] [Abstract][Full Text] [Related]
20. Insulin-like growth factors in patients with nonislet cell tumors and hypoglycemia.
Merimee TJ
Metabolism; 1986 Apr; 35(4):360-3. PubMed ID: 2421134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
